← Leaderboards
Connor Patrick Francis
University Of Florida
$233,985
Attributed
$233,985
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2021–25$100K$75K$50K$25K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$233,985 · 1
By mechanism
F30$233,985 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Catherine T Flores$4,894,915
- Stephen Patrick Hunger$7,938,370
- Bryon E Petersen$7,531,216
- Susana T Valente$35,884,894
- Maureen M Goodenow$10,117,946
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignDraining Lymph NodeAdoptive TransferAblationData DisplayDendritic CellsAnti-Pd1 TherapyAnti-Tumor Immune ResponseAntitumor ResponseAutoreactivityAffectBeta Chain Antigen T Cell ReceptorBindingCancer EtiologyCancer PatientCd8b1 GeneCell PhysiologyCentral Nervous System NeoplasmsChildhood Cancer MortalityChildhood GliomaClinical Decision-MakingClinical ManagementCombined Modality TherapyEnsure
Grant awards (5)
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$54,538
F30 · FY2025 · CA · contact PI
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$53,974
F30 · FY2024 · CA · contact PI
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$42,691
F30 · FY2023 · CA · contact PI
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$41,749
F30 · FY2022 · CA · contact PI
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma$41,033
F30 · FY2021 · CA · contact PI